Double Trouble: Functional Suppression of a Prolactinoma by a Dopamine-Secreting Paraganglioma

Published on September 22, 2026

A recent JCEM Case Reports article describes a 52-year-old male who presented with cerebrospinal fluid rhinorrhea and was found to have an invasive, 4.2-cm pituitary mass with modestly elevated prolactin. When the surgeons resected the tumor, it revealed another. Two rare endocrine tumors occurring recurrently. Endocrine News speaks with the lead author, who shared the […]

The post Double Trouble: Functional Suppression of a Prolactinoma by a Dopamine-Secreting Paraganglioma appeared first on Endocrine News.

Continue reading on website
Other news

Pharma Friday – September 18, 2026

September 18, 2026
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Bayer’s KERENDIA® (finerenone) Receives FDA Approval as the First New Treatment in 30 Years for Adults with Chronic Kidney Disease (CKD) and Type 1 Diabetes KERENDIA® (finerenone), a non-steroidal mineralocorticoid receptor antagonist (MRA), is the first new treatment in more than 30 years […]The

Testicular Adrenal Rest Tumors Could Point to Late-Diagnosis CAH: Case Report

September 22, 2026
Researchers in Brazil recently published a paper in JCEM Case Reports, detailing a 22-year-old man who developed am acute adrenal crisis following bitalteral orchiectomy for testicular tumors. The authors, of the paper, “Acute adrenal crisis after orchiectomy for testicular adrenal rest tumors in untreated congenital adrenal hyperplasia,” point out that this patient had untreated congenital […]The